Northwire Canada EditionThursday, October 15, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Financings Routine −

Grey Matters Announces Private Placement

Grey Matters Health Raises Capital at Discount to Fund US Clinic Expansion Amidst Dilution Concerns

By The Northwire Desk — AI Analysis Apr 22, 2026 · 07:00 GREY · 0.495 Grey Matters Health Inc.
Executive Summary
  • Grey Matters Health Inc. announced a non-brokered private placement on 2026-04-22.
  • The offering targets gross proceeds of CAD $1,000,000.
  • Units are priced at CAD $0.40 per unit, representing a 20% discount to the previous trading day's close of $0.50.
  • Proceeds are designated for advancing the Alzheimer’s Disease program and opening the first U.S.-based neuroimaging clinic.
  • General working capital and administrative expenses will also be funded by this raise.
  • Each unit includes one Class A common share and one Common Share purchase warrant.
  • Warrants have an exercise price of CAD $0.60 with a 24-month expiry, subject to acceleration if the stock trades above $0.80 for 10 consecutive days.
  • Finder's fees up to 8% of proceeds may be paid in cash or finders warrants.
Material Impact
  • The financing is dilutive to existing shareholders due to the issuance of new shares and warrants at a discount to market price.
  • A 20% discount ($0.40 vs $0.50) signals potential weakness or an urgent need for liquidity, which typically suppresses stock sentiment in the short term.
  • The capital raise amount ($1M CAD) is relatively small; while it extends runway, it may not be sufficient to fully fund a U.S. clinic opening without further financing rounds later.
  • Warrants introduce future dilution risk if the share price recovers above $0.60, though they are currently out-of-the-money relative to the previous close ($0.50).
  • The acceleration clause creates an incentive for management to drive share price volatility or positive news to trigger warrant expiry, potentially increasing float pressure in 24 months.
  • Given the lack of historical financial data, it is unclear if this capital is a lifeline against insolvency or simply operational expansion; risk aversion suggests caution regarding cash burn rates.
GREY · Price
Company Overview
  • Company: Grey Matters Health Inc.
  • Flagship Project: Alzheimer’s Disease program focusing on neuroimaging.
  • Development Stage: Advancing towards opening a first U.S.-based brain-specific neuroimaging clinic.
  • Business Model: Likely service-based or diagnostic imaging focused on neurological conditions, specifically dementia/Alzheimer's.
  • Strategic Focus: Expansion into the U.S. market from its current base (likely Canada given CAD currency).
Read the original news release →

More from Grey Matters Health Inc.

Jun 05, 2026 · 16:01

Grey Matters Health Secures $500K Tranche as Florida Neuroimaging Clinics Edge Closer to Opening

Financings May 25, 2026 · 07:00

Grey Matters Amends Warrant Terms to Secure Financing as Clinic Expansion Nears; Stock Holds Near Issue Price

Financings May 20, 2026 · 07:00

Grey Matters Health Signs LOI for Tampa Trial, Yet Dilution and Timeline Risks Persist

Other